The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
330 jobs Number of planned job creations
Announcement Date
31 March 2026
Employment effect (start)
1 January 2026
Foreseen end date
30 April 2026
Description
US-headquartered pharmaceutical multinational, West Pharmaceutical Services has created 330 new jobs as a result of opening of a major manufacturing expansion at its Damastown site in Dublin. Most of the roles have already been filled.
The new facility was officially launched in March 2026 and supports high volume production of drug delivery systems used in treatments for diabetes and obesity.
Public authorities were involved in welcoming the investment. IDA Ireland and the Minister for Public Expenditure, Infrastructure, Public Service Reform and Digitalisationwelcomed the opening of the new facility, describing it as beneficial for both the local community and the national life sciences sector.
The company employs more than 10,000 people in 50 global locations, including 1,400 in Ireland across sites in Dublin and Waterford. West said the investment strengthens its global manufacturing capacity and underlines Ireland’s role as a hub for advanced pharmaceutical and medtech production.
Eurofound (2026), West Pharmaceuticals, Business expansion in Ireland, factsheet number 204572, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/204572.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...